Levetiracetam in Central Pain in Multiple Sclerosis(MS)

Summary

Multiple sclerosis is often associated with pain. There is no standard treatment of this type of pain. Levetiracetam is a new anticonvulsant and it is the hypothesis that it could relieve central pain in multiple sclerosis. This is a randomised, double-blind, placebo-controlled, cross-over trial on the effect of levetiracetam 3000 mg daily on pain in multiple sclerosis.

Timeline

Start

2007-01

Primary completion

2009-01

Completion

2009-01

Drugs

Indications